Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Neurology

What is the Enroll-HD Study for Huntington's Disease?

At a Glance

Enroll-HD is the world's largest observational study for Huntington disease. It tracks the health of HD patients, at-risk individuals, and family members over time without using experimental drugs. Participation involves a single annual clinical visit to help scientists develop future treatments.

Enroll-HD is the largest observational study in the world dedicated to Huntington disease (HD) [1]. An observational study is very different from a clinical drug trial—if you participate in Enroll-HD, you will not be asked to take any experimental medications or change your current medical care [2]. Instead, researchers simply observe and track your health over time to better understand how HD progresses [3]. Participating in this study is a safe, impactful way to contribute to HD research and help scientists develop future treatments, even if you have no interest in testing new drugs yourself [4].

Who Can Join Enroll-HD?

You do not need to have active symptoms or even a positive genetic test to participate. The study is open to almost anyone connected to an HD family [1]. By comparing data from different groups, researchers can more easily identify what changes are truly caused by the HD gene [5]. Eligible participants include:

  • Gene-positive individuals: People who have the HD gene expansion, whether they currently have symptoms (manifest) or are completely symptom-free (premanifest) [6].
  • Gene-negative individuals: Blood relatives who have been tested and do not carry the HD gene [1].
  • At-risk individuals: People who have a parent with HD but have chosen not to undergo predictive genetic testing. You will not be forced to learn your genetic status to join [7].
  • Spouses and caregivers: Partners or non-blood family members who share a living environment with an HD patient. They act as a crucial “control group” for comparison [1].

What Does the Study Involve?

Participation typically involves a single clinical visit once a year [8]. The length of the visit can vary, but you can usually expect it to take 2 to 3 hours. During this visit, a research team will conduct a series of standard checks to measure your physical and mental health. These annual assessments usually include:

  • Motor evaluations: Physical tests to check your movement, balance, and coordination [1].
  • Cognitive assessments: Puzzles and memory tasks, such as matching symbols and numbers, to evaluate how your brain processes information [9].
  • Behavioral and functional reviews: Questionnaires discussing your mood, emotional well-being, and ability to handle daily tasks [5].
  • Biological samples: Providing a blood sample to help researchers study biomarkers (measurable biological signs of the disease) [1].

Is My Information Private?

A common and valid concern regarding research is the privacy of genetic and medical data. In Enroll-HD, your personal identity is rigorously protected. Before your health information is added to the global database, your name and other identifying details are removed and replaced with a unique, encrypted code [1][3]. This process (called de-identification) ensures that scientists worldwide can study the trends in your data, but they cannot trace the information back to you personally.

How Your Participation Helps

Because Huntington disease affects every person differently, scientists need massive amounts of data to map out the “natural history”—or typical progression over time—of the disease [3]. Enroll-HD creates a global database that allows scientists to track long-term symptom trajectories and understand what factors might speed up or slow down disease progression [8].

Furthermore, having this rich, long-term observational data is absolutely essential for designing safe and effective clinical drug trials [4]. Before researchers can test if a new drug works, they use Enroll-HD data to understand what symptoms to target and how to measure success [10]. Many participants report that joining the study gives them a better understanding of the disease, a strong relationship with a specialized care team, and a deep sense of purpose in the fight against HD [11].

Cost and How to Sign Up

Joining the study is completely voluntary and free of charge [12]. It will not be billed to your health insurance. To participate, you can search for a clinical site near you—often located at specialized HD clinics or academic medical centers—via the official Enroll-HD website or by speaking directly with your local neurologist [1]. Many local sites also provide small stipends or reimbursements for travel and parking to ensure that volunteering is not a financial burden.

Common questions in this guide

Do I have to take experimental drugs in the Enroll-HD study?
No. Enroll-HD is strictly an observational study. You will not be asked to take any experimental medications or change your current medical care. Researchers simply track your health over time to understand how Huntington disease progresses.
Can I join Enroll-HD if I haven't been tested for the Huntington gene?
Yes. At-risk individuals who have not undergone predictive genetic testing can participate. The study has safeguards in place, and you will not be forced to learn your genetic status to join the study.
What happens during an Enroll-HD annual visit?
A typical annual visit takes two to three hours and includes physical motor evaluations, cognitive puzzles, and behavioral questionnaires. You will also be asked to provide a blood sample to help researchers study measurable biological signs of the disease.
Will my personal medical data be kept private in the Enroll-HD study?
Yes, your personal identity is rigorously protected. Before your health information is shared with scientists worldwide, your name and identifying details are removed and replaced with a unique, encrypted code so the data cannot be traced back to you.
Can spouses or caregivers participate in Enroll-HD?
Yes, partners and non-blood family members who share a living environment with a Huntington disease patient can join. They act as a crucial control group for researchers to compare against individuals with the gene.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is our local clinic an active Enroll-HD study site, or would I need to travel to participate?
  2. 2.If I am an at-risk family member who hasn't been tested, what safeguards does the clinic have in place to ensure I do not accidentally find out my genetic status?
  3. 3.Are the results of my annual cognitive and motor tests shared with me to help manage my care, or are they kept strictly for research purposes?
  4. 4.If I do decide I want to join a clinical drug trial in the future, how does participating in Enroll-HD affect my eligibility?
  5. 5.If my mobility declines in the later stages of the disease, are there remote options for participating, or can I withdraw without penalty?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    Data Analytics from Enroll-HD, a Global Clinical Research Platform for Huntington's Disease.

    Landwehrmeyer GB, Fitzer-Attas CJ, Giuliano JD, et al.

    Movement disorders clinical practice 2017; (4(2)):212-224 doi:10.1002/mdc3.12388.

    PMID: 30363395
  2. 2

    Incidence of completed suicide and suicide attempts in a global prospective study of Huntington's disease.

    van Duijn E, Fernandes AR, Abreu D, et al.

    BJPsych open 2021; (7(5)):e158 doi:10.1192/bjo.2021.969.

    PMID: 34462049
  3. 3

    Ranking the Predictive Power of Clinical and Biological Features Associated With Disease Progression in Huntington's Disease.

    Ghazaleh N, Houghton R, Palermo G, et al.

    Frontiers in neurology 2021; (12()):678484 doi:10.3389/fneur.2021.678484.

    PMID: 34093422
  4. 4

    Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease.

    Di Tella S, Lo Monaco MR, Petracca M, et al.

    Journal of neurology 2022; (269(12)):6634-6640 doi:10.1007/s00415-022-11297-3.

    PMID: 35915275
  5. 5

    Enroll-HD: An Integrated Clinical Research Platform and Worldwide Observational Study for Huntington's Disease.

    Sathe S, Ware J, Levey J, et al.

    Frontiers in neurology 2021; (12()):667420 doi:10.3389/fneur.2021.667420.

    PMID: 34484094
  6. 6

    Sleep Quality and Related Clinical Manifestations in Huntington Disease.

    Maffi S, Scaricamazza E, Migliore S, et al.

    Journal of personalized medicine 2022; (12(6)) doi:10.3390/jpm12060864.

    PMID: 35743649
  7. 7

    "It's being part of the big picture, even though you're a tiny jigsaw piece"-motivations and expectations of individuals participating in the Enroll-HD observational study.

    Davies E, Craufurd D, MacLeod R

    Journal of community genetics 2020; (11(4)):421-432 doi:10.1007/s12687-020-00459-3.

    PMID: 32157658
  8. 8

    A Phenotypic Atlas for Huntington Disease Based on Data From the Enroll-HD Cohort Study.

    Langbehn DR, Sathe SS, Loy C, et al.

    Neurology. Genetics 2023; (9(6)):e200111 doi:10.1212/NXG.0000000000200111.

    PMID: 38035176
  9. 9

    Identification of symbol digit modality test score extremes in Huntington's disease.

    Braisch U, Muche R, Rothenbacher D, et al.

    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2019; (180(3)):232-245 doi:10.1002/ajmg.b.32719.

    PMID: 30788902
  10. 10

    Forecasting individual progression trajectories in Huntington disease enables more powered clinical trials.

    Koval I, Dighiero-Brecht T, Tobin AJ, et al.

    Scientific reports 2022; (12(1)):18928 doi:10.1038/s41598-022-18848-8.

    PMID: 36344508
  11. 11

    Striving for a Realistic and Unapologetic View of Huntington's Disease.

    Serbin KP

    Journal of Huntington's disease 2022; (11(4)):369-371 doi:10.3233/JHD-220551.

    PMID: 36502336
  12. 12

    Validation of a prognostic index for Huntington's disease.

    Long JD, Langbehn DR, Tabrizi SJ, et al.

    Movement disorders : official journal of the Movement Disorder Society 2017; (32(2)):256-263 doi:10.1002/mds.26838.

    PMID: 27892614

This page provides educational information about the Enroll-HD observational study. Always speak with your neurologist or an HD clinic specialist to discuss research participation and your specific medical care.

Get notified when new evidence is published on Huntington disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.